The biggest names in corporate America call the Dow Jones (^DJI) home, but only a handful are still growing at a strong pace. Some of these blue-chip stocks are standing out by adapting to change and driving shareholder value.
Even among blue-chip stocks, only a few shine bright, and we’re here to help you find them. Keeping that in mind, here are three Dow Jones stocks positioned for long-term growth.
Amazon (AMZN)
Market Cap: $2.68 trillion
Founded by Jeff Bezos after quitting his stock-picking job at D.E. Shaw, Amazon (NASDAQ: AMZN) is the world’s largest online retailer and provider of cloud computing services.
Why Are We Positive on AMZN?
- Amazon revolutionized the way consumers shop. This isn’t the only tailwind to its impressive revenue growth, as its highly profitable AWS segment has also driven top-line momentum.
- The company’s best-in-class revenue growth coupled with modest operating leverage on its past infrastructure investments has led to elite EPS growth over a multi-year period.
- Though dominant, Amazon’s capital-intensive e-commerce business means its profitability is structurally lower than its pure-play tech peers. Can the company pull it up, or are we reaching a ceiling?
At $248.83 per share, Amazon trades at 27.4x forward price-to-earnings. Is now a good time to buy? See for yourself in our comprehensive research report, it’s free.
Nvidia (NVDA)
Market Cap: $5.57 trillion
Founded in 1993 by Jensen Huang and two former Sun Microsystems engineers, Nvidia (NASDAQ: NVDA) is a leading fabless designer of chips used in gaming, PCs, data centers, automotive, and a variety of end markets.
Why Will NVDA Outperform?
- Annual revenue growth of 77.4% over the past two years was outstanding, reflecting market share gains this cycle
- Share repurchases over the last five years enabled its annual earnings per share growth of 82.6% to outpace its revenue gains
- Robust free cash flow margin of 42.5% gives it many options for capital deployment, and its rising cash conversion increases its margin of safety
Nvidia is trading at $231.49 per share, or 18.9x forward P/E. Is now the time to initiate a position? Find out in our full research report, it’s free.
Amgen (AMGN)
Market Cap: $220.2 billion
Founded in 1980 during the early days of the biotechnology revolution, Amgen (NASDAQ: AMGN) is a biotechnology company that discovers, develops, and manufactures innovative medicines to treat serious illnesses like cancer, osteoporosis, and autoimmune diseases.
Why Do We Like AMGN?
- Revenue base of $38.1 billion gives it economies of scale and some negotiating power
- Impressive free cash flow profitability enables the company to fund new investments or reward investors with share buybacks/dividends
- Market-beating returns on capital illustrate that management has a knack for investing in profitable ventures
Amgen’s stock price of $408.04 implies a valuation ratio of 17.9x forward P/E. Is now the right time to buy? See for yourself in our in-depth research report, it’s free.
Stocks We Like Even More
ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.
Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as ServiceNow (+164% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+1,154% between June 2020 and June 2025). Find your next big winner with StockStory today.
